Last modified: September 25, 2024
Home
NewsPRESS RELEASE(Bilateral Discussion on Implementation of the Agreement signed for recognition of official control exercised by BFDA and FSSAI, India)
PRESS RELEASE(Bilateral Discussion on Implementation of the Agreement signed for recognition of official control exercised by BFDA and FSSAI, India)
Recent Posts
- Public Consultation on “National Vigilance Strategy for Medical Products 2025”
- Press release on ByHeart Infant Formula
- BFDA Public Health Advisory on substandard product confirmed by the Thai Food and Drug Administration via the South East Asia Regulatory Network (SEARN)
- Regulatory Notification on the Recall of Herbal Product COMPOUND HERB INHALER (HONGTHAI BRAND FORMULA 2)
- Competency Examination on 05 January, 2026
Recent Posts
-
Press release on ByHeart Infant Formula
November 21, 2025
Bhutan Food and Drug Authority
- Ministry of Health,
- Kawajangsa,
- Tashichhodzong, Thimphu
- Toll Free No: 1555
- Post box : 1071
- Email: bfdahq@bfda.gov.bt
Disclaimer: Subject to change; verify with authorities.
Copyright © 2025 - BFDA